128 related articles for article (PubMed ID: 8461554)
1. Total body absorptiometry in postmenopausal osteoporosis patients treated with 1 alpha-hydroxylated vitamin D metabolites.
Caniggia A; Nuti R; Loré F; Martini G; Frediani B; Giovani S
Osteoporos Int; 1993; 3 Suppl 1():181-5. PubMed ID: 8461554
[No Abstract] [Full Text] [Related]
2. Role of the active vitamin D metabolite and 1 alpha-hydroxylated analogs in the treatment of postmenopausal osteoporosis.
Caniggia A; Loré F; Nuti R; Martini G; Frediani B; Di Cairano G
J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():232-5. PubMed ID: 1297745
[No Abstract] [Full Text] [Related]
3. Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal women.
Hartwell D; Riis BJ; Christiansen C
Calcif Tissue Int; 1990 Dec; 47(6):332-7. PubMed ID: 2292078
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with calcitriol in postmenopausal osteoporosis.
Caniggia A; Nuti R; Lore F; Martini G; Turchetti V; Righi G
Metabolism; 1990 Apr; 39(4 Suppl 1):43-9. PubMed ID: 2325571
[TBL] [Abstract][Full Text] [Related]
5. The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status.
Need AG; Morris HA; Horowitz M; Nordin BE
Calcif Tissue Int; 1997 Jul; 61(1):6-9. PubMed ID: 9192503
[TBL] [Abstract][Full Text] [Related]
6. [Postmenopausal osteoporosis. Digital Rx radiogrammetry in the diagnosis and follow-up of treatment with alfacalcidol].
Galeşanu C; Ciubotariu C; Melnic G; Galeşanu MR
Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):833-41. PubMed ID: 17438884
[TBL] [Abstract][Full Text] [Related]
7. Effects of a combined alendronate and calcitriol agent (Maxmarvil) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study.
Rhee Y; Kang M; Min Y; Byun D; Chung Y; Ahn C; Baek K; Mok J; Kim D; Kim D; Kim H; Kim Y; Myoung S; Kim D; Lim SK
Osteoporos Int; 2006 Dec; 17(12):1801-7. PubMed ID: 17019520
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density.
Gutteridge DH; Holzherr ML; Retallack RW; Price RI; Will RK; Dhaliwal SS; Faulkner DL; Stewart GO; Stuckey BG; Prince RL; Criddle RA; Drury PJ; Tran L; Bhagat CI; Kent GN; Jamrozik K
Calcif Tissue Int; 2003 Jul; 73(1):33-43. PubMed ID: 14506952
[TBL] [Abstract][Full Text] [Related]
9. Calcium absorption in normal and osteoporotic postmenopausal women.
Morris HA; Need AG; Horowitz M; O'Loughlin PD; Nordin BE
Calcif Tissue Int; 1991 Oct; 49(4):240-3. PubMed ID: 1760766
[TBL] [Abstract][Full Text] [Related]
10. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of thiazide and 1,25-(OH)2 vitamin D in postmenopausal osteoporosis.
Sakhaee K; Zisman A; Poindexter JR; Zerwekh JE; Pak CY
Osteoporos Int; 1993 Jul; 3(4):209-14. PubMed ID: 8338977
[TBL] [Abstract][Full Text] [Related]
12. Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study.
Gürlek A; Bayraktar M; Gedik O
Calcif Tissue Int; 1997 Jul; 61(1):39-43. PubMed ID: 9192511
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
[TBL] [Abstract][Full Text] [Related]
14. Treatment of osteoporosis with vitamin D.
Kanis JA; McCloskey EV; de Takats D; Bernard J; Zhang DM
Osteoporos Int; 1997; 7 Suppl 3():S140-6. PubMed ID: 9536320
[No Abstract] [Full Text] [Related]
15. [Methodological basis and clinical applications of total-body densitometry].
Nuti R; Martini G; Frediani B; Giovani S; Valenti R
Minerva Endocrinol; 1992; 17(4):173-81. PubMed ID: 1308921
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment with calcitonin and 1,25-dihydroxyvitamin D3 for osteoporosis in women.
Eriksson SA; Lindgren JU
Calcif Tissue Int; 1993 Jul; 53(1):26-8. PubMed ID: 8348381
[TBL] [Abstract][Full Text] [Related]
17. Calcium and calcitriol therapy in osteoporotic postmenopausal women with impaired calcium absorption.
Need AG; Nordin C; Horowitz M; Morris HA
Metabolism; 1990 Apr; 39(4 Suppl 1):53-4. PubMed ID: 2325573
[TBL] [Abstract][Full Text] [Related]
18. Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis.
Orimo H; Shiraki M; Hayashi Y; Hoshino T; Onaya T; Miyazaki S; Kurosawa H; Nakamura T; Ogawa N
Calcif Tissue Int; 1994 May; 54(5):370-6. PubMed ID: 8062152
[TBL] [Abstract][Full Text] [Related]
19. Role of calcitriol in prevention of osteoporosis: Part I.
Drezner MK; Nesbitt T
Metabolism; 1990 Apr; 39(4 Suppl 1):18-23. PubMed ID: 2325566
[TBL] [Abstract][Full Text] [Related]
20. New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis.
Guerrero R; Diaz Martin MA; Diaz Diego EM; Disla T; Rapado A; de la Piedra C
Osteoporos Int; 1996; 6(4):297-302. PubMed ID: 8883118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
